Comorbidity Burden May Increase After Binge Eating Disorder Diagnosis
Patients may be at risk for increased comorbidity burden after a diagnosis of binge eating disorder.
Patients may be at risk for increased comorbidity burden after a diagnosis of binge eating disorder.
The Endocrine Society published a clinical practice guideline cosponsored by the American Diabetes Association and the European Society of Endocrinology regarding the primary prevention of ASCVD and T2D.
Dr Gottlieb expressed that the FDA is committed to bringing competition to the insulin market to lower prices and expand patient access.
The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) published an annual update to their joint algorithm for the management of type 2 diabetes (T2D). This guide incorporates evidence-based approaches to aid in choosing treatment courses for patients, based on underlying risk factors and personal preferences. With a focus on obesity,…
The Endocrine Society has objected the US Department of Health & Human Services’ update to the Title X Family Planning Program.
The American Diabetes Association issued a position statement outlining the recognition, management, and prevention of T2D in the pediatric population.
The Endocrine Society has expressed concern regarding the FDA’s position on use of BPA in commercial products.
Recommendations in the report highlight the importance of patient-centered decision making for glycemic management and improving diet and exercise for patients with T2D.